1. Teng, Jing-Jing, Zhao, Wen-Jing, Zhang, Xun-Lei, Chen, Xu-Dong, Yang, Lei. 2021. Downregulation of promoter methylation gene PRDM5 contributes to the development of tumor proliferation and predicts poor prognosis in gastric cancer. In Journal of Cancer, 12, 6921-6930. doi:10.7150/jca.59998. https://pubmed.ncbi.nlm.nih.gov/34659579/
2. Zhang, Chunyang, Liu, Ziyang, Sheng, Yinliang, Qi, Yu, Zhao, Song. 2021. PRDM5 suppresses oesophageal squamous carcinoma cells and modulates 14-3-3zeta/Akt signalling pathway. In Clinical and experimental pharmacology & physiology, 49, 370-379. doi:10.1111/1440-1681.13612. https://pubmed.ncbi.nlm.nih.gov/34757658/
3. Seehawer, Marco, Heinzmann, Florian, D'Artista, Luana, Bischof, Oliver, Zender, Lars. 2018. Necroptosis microenvironment directs lineage commitment in liver cancer. In Nature, 562, 69-75. doi:10.1038/s41586-018-0519-y. https://pubmed.ncbi.nlm.nih.gov/30209397/
4. Sanrı, Aslıhan, Demir, Selma, Gurkan, Hakan. 2022. Homozygous Val6Gly Variation in PRDM5 Gene Causing Brittle Cornea Syndrome: A New Turkish Case. In Molecular syndromology, 14, 129-135. doi:10.1159/000524832. https://pubmed.ncbi.nlm.nih.gov/37064337/
5. Guo, Qixin, Zhu, Qingqing, Zhang, Ting, Shi, Mengsha, Li, Xinli. 2022. Integrated bioinformatic analysis reveals immune molecular markers and potential drugs for diabetic cardiomyopathy. In Frontiers in endocrinology, 13, 933635. doi:10.3389/fendo.2022.933635. https://pubmed.ncbi.nlm.nih.gov/36046789/
6. Sklar, Bonnie A, Pisuchpen, Phattrawan, Bareket, Mor, Levin, Alex V, Hammersmith, Kristin. 2023. Identification and Management of a Novel PRDM5 Gene Pathologic Variant in a Family With Brittle Cornea Syndrome. In Cornea, 42, 1572-1577. doi:10.1097/ICO.0000000000003372. https://pubmed.ncbi.nlm.nih.gov/37713669/
7. Guo, Jing, Yang, Qiuxing, Wei, Sheng, Chen, Jia, Wang, Gaoren. 2022. Low expression of PRDM5 predicts poor prognosis of esophageal squamous cell carcinoma. In BMC cancer, 22, 745. doi:10.1186/s12885-022-09787-8. https://pubmed.ncbi.nlm.nih.gov/35799142/
8. Couto, Joana Pinto, Vulin, Milica, Jehanno, Charly, Mertz, Kirsten D, Bentires-Alj, Mohamed. 2023. Nicotinamide N-methyltransferase sustains a core epigenetic program that promotes metastatic colonization in breast cancer. In The EMBO journal, 42, e112559. doi:10.15252/embj.2022112559. https://pubmed.ncbi.nlm.nih.gov/37259596/